The compounder 
AVGO has declined almsot 20% from ATHs. The stock is trading around $325 as we speak, currently testing the 100 SMA, if it breaks below, a gap could be filled around $310:$300.
Keys:
A disparity between the trailing P/E of 71 and the anticipated forward 24x suggests that the company is expecting a massive earnings boom.
PEG of 0.69 is suggesting an undervalued stock price to its growth.
A fortress balance sheet with a profit margin of 36.20% & gross margin of 64,71% & EPS next y of 38,21%
AVGO has declined almsot 20% from ATHs. The stock is trading around $325 as we speak, currently testing the 100 SMA, if it breaks below, a gap could be filled around $310:$300. Keys:
A disparity between the trailing P/E of 71 and the anticipated forward 24x suggests that the company is expecting a massive earnings boom.
PEG of 0.69 is suggesting an undervalued stock price to its growth.
A fortress balance sheet with a profit margin of 36.20% & gross margin of 64,71% & EPS next y of 38,21%
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。